|
LCD ID Number: L34426 Status: A-Approved
LCD Title: Ophthalmic Angiography (Fluorescein and Indocyanine Green)
Geographic Jurisdiction: Georgia Other Jurisdictions
Original Determination Effective Date:
10/01/2015
Original Determination Ending Date:
Revision Effective Date:
07/15/2021
Revision End Date:
CMS National Coverage Policy:
Title XVIII of the Social Security Act, §1862(a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.
Title XVIII of the Social Security Act, §1862(a)(14) defines other than physician services.
Title XVIII of the Social Security Act, §1862(a)(7) states Medicare will not cover any services or procedures associated with routine physical exams.
42 CFR §410.32(a) indicates that diagnostic tests may only be ordered by the treating physician (or other treating practitioner acting within the scope of his or her license and Medicare requirements).
42 CFR §410.74 defines physician assistants' services.
42 CFR §410.75 defines nurse practitioners' services.
42 CFR §410.76 defines clinical nurse specialists' services.
CMS Internet-Only Manual, Pub 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 1, §80.2 Photodynamic Therapy, §80.2.1 Ocular Photodynamic Therapy (OPT) - Effective April 3, 2013, §80.3 Photosensitive Drugs and §80.3 Verteporfin - Effective April 3, 2013
Sorry, you need to login or register to view additional sections of this Medicare policy.
*
|
Printer Friendly Version